Medpace (MEDP) closed the most recent trading day at $461.60, moving -1.26% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 0.57%. Meanwhile, the Dow ...

In early June 2026, Medpace Holdings appointed long-time insider Brad W. Hansman as Executive Vice President, Operations, sharing principal operating officer responsibilities with Susan E. Burwig. At ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Medpace Holdings Inc. faces securities fraud allegations for alleged understatement of cancellation rates and overstatement of book-to-bill ratio, causing a 16% single day stock drop; investors urged ...

Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q1 CY2026 results , with sales up 26.5% year on year to $706.6 million. The company expects the full year’s revenue to be around $2.81 ...

Medpace Hldgs (NASDAQ:MEDP) is gearing up to announce its quarterly earnings on Monday, 2024-10-21. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

Medpace (MEDP Quick Quote MEDP - Free Report) closed at $501.23 in the latest trading session, marking a +1.56% move from the prior day. This change outpaced the S&P 500's 1.02% gain on the day.

Medpace MEDP reported strong second-quarter results highlighted by revenue of nearly $461 million, representing a 31% increase from the prior-year period. Medpace is tracking our expectations, and we ...

Medpace (MEDP Quick Quote MEDP - Free Report) closed the most recent trading day at $466.80, moving +1.32% from the previous trading session. The stock's change was more than the S&P 500's daily gain ...